
zzso for zzso are common in patients with zzso Cancer patients have an increased risk of developing zzso zzso events or may have other indications for zzso such as zzso zzso New oral zzso zzso are now available that offer increased options for zzso beyond the traditional vitamin K zzso and low molecular weight zzso that have long been the cornerstone of zzso This review will focus on the three zzso that are currently approved for use in the zzso the direct zzso zzso zzso and the factor zzso zzso zzso and zzso zzso are likely to encounter an increasing number of patients taking these agents at the time of their cancer diagnosis or to have patients who develop indications for zzso during the course of their zzso The basic zzso current clinical zzso and approach to the use of zzso in the cancer patient will be zzso 

